3387 studies found for:    Japan
Show Display Options
Rank Status Study
1 Active, not recruiting A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: E0302 (mecobalamin);   Drug: Placebo
2 Completed
Has Results
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
Condition: Refractory Reflux Esophagitis
Intervention: Drug: E3810
3 Completed
Has Results
Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain
Condition: Pain
Interventions: Drug: Celecoxib;   Drug: Placebo
4 Completed Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion
Condition: Malignant Pericardial Effusion
Interventions: Procedure: Observation alone after pericardial drainage;   Drug: Pericardial instillation of bleomycin after drainage
5 Recruiting Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B
Conditions: HBV;   Chronic HBV Infections
Interventions: Drug: Tenofovir alafenamide;   Drug: Tenofovir disoproxil fumarate;   Drug: Placebo to match tenofovir alafenamide;   Drug: Placebo to match tenofovir DF
6 Recruiting A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.
Condition: Colitis, Ulcerative
Interventions: Drug: Golimumab;   Other: Placebo
7 Recruiting A Study of Kadcyla (Trastuzumab Emtansine) Plus Perjeta (Pertuzumab) Following Anthracyclines in Comparison With Herceptin (Trastuzumab) Plus Perjeta and a Taxane Following Anthracyclines as Adjuvant Therapy in Patients With Operable HER2-Positive Primary Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anthracycline-based chemotherapy;   Drug: pertuzumab [Perjeta];   Drug: taxane;   Drug: trastuzumab emtansine [Kadcyla];   Drug: trastuzumab [Herceptin]
8 Completed
Has Results
Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Warfarin;   Drug: Rivaroxaban placebo;   Drug: Warfarin placebo
9 Completed
Has Results
A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease
Condition: Non-erosive Gastroesophageal Reflux Disease
Interventions: Drug: E3810;   Drug: Placebo
10 Completed Add-on to Micamlo BP Trial
Condition: Hypertension
Interventions: Drug: Telmisartan + amlodipine;   Drug: hydrochlorothiazide;   Drug: Placebo
11 Unknown  Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
Condition: Colorectal Cancer
Interventions: Drug: tegafur-uracil;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis
12 Recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
13 Completed Study of TAK-816 in Healthy Infants
Condition: Immunization
Interventions: Biological: TAK-816+ DPT-TAKEDA;   Biological: ActHIB+ DPT-TAKEDA
14 Active, not recruiting Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
Condition: Acromegaly, Pituitary Gigantism
Intervention: Drug: SOM230LAR
15 Completed
Has Results
Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
Condition: Dysmenorrhea
Interventions: Drug: DRSP 3 mg/EE 20 µg (13 cycles);   Drug: DRSP 3 mg/EE 30 µg (6 cycles)
16 Completed Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections
Condition: Mycobacterium Infections, Atypical
Intervention:
17 Recruiting Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Vedolizumab;   Drug: Vedolizumab placebo
18 Completed Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis
Condition: Onychomycosis
Interventions: Drug: IDP-108;   Drug: Vehicle
19 Terminated A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Menatetrenone;   Drug: Placebo
20 Recruiting The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)
Condition: Chronic Heart Failure
Interventions: Drug: Bisoprolol;   Drug: Carvedilol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years